Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation

Area of Science:

• Immunology
• Biochemistry
• Computational Biology

Background:

• CD59 is a human protein that regulates the immune system by inhibiting the complement cascade.
• Viruses like HIV-1 and cancer cells exploit CD59 to evade complement-mediated destruction.
• Antibodies targeting CD59 show therapeutic potential against viral infections and cancer.

Purpose of the Study:

• To identify CD59 interactions with blocking antibodies using bioinformatics.
• To characterize the molecular details of antibody-epitope interfaces.
• To design and produce novel peptide-based therapeutics mimicking antibody functions.

Main Methods:

• Bioinformatics analysis of CD59-antibody interactions.
• Computational modeling of paratope-epitope interfaces.
• Design and synthesis of bicyclic peptides mimicking antibody binding sites.

Main Results:

• Identified key molecular interactions between CD59 and blocking antibodies.
• Characterized the paratope-epitope interface at a molecular level.
• Successfully designed and produced bicyclic peptides that target CD59.

Conclusions:

• The developed peptides mimic antibody functions and target CD59.
• These antibody-mimicking peptides represent a new class of small molecules.
• Potential therapeutic applications include complement activation for treating viral infections and cancer.